Skip to main content
Signal8

Telo Genomics Corp. (TDSGF)

Telo Genomics Corp. is a biotechnology enterprise focused on developing and commercializing sophisticated predictive technologies. Their mission is to enable personalized treatment approaches for patients facing specific health challenges. The company's central offering is a telomere analysis platform, which provides both diagnostic insights and prognostic assessments. This platform leverages liquid biopsies and related innovations, with a particular emphasis on applications within oncology (cancer) and neurological diseases. A flagship product, Telo-MM, is a solution designed to equip healthcare professionals with crucial, actionable information for managing Multiple Myeloma, a type of blood cancer. Additionally, the company provides TeloView, a proprietary software platform used to precisely measure specific telomere features unique to each patient. Telo Genomics serves a diverse client base, including pathologists, clinicians, academic researchers, and drug developers. They have a collaborative agreement with the Mayo Clinic to conduct validation studies for their Telo-MM tests concerning multiple myeloma. Founded in 2014, the company was initially known as 3D Signatures Inc. before officially changing its name to Telo Genomics Corp. in April 2019. Its headquarters are located in Toronto, Canada.

Sector: Medical - Diagnostics & Research

Industry: Medical - Diagnostics & Research

Telo Genomics Corp. logo

Telo Genomics Corp.

OTC:TDSGFHealthcare
CLOSED
Mkt Cap-
EV-
Float97.41M
O/S100.43M
VOL200 sh
$ Vol$6
RVOL0.04×
Inst Own-
SI<0.1%
Net Cash/Sh-$0.01
Dilution
Financials Summary
Revenue$0
Net Income-$1.56M
Total Assets$420K
Free Cash Flow-$1.09M
Debt & Equity
Total Debt$1.01M
Total Equity-$1.11M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
  1. 1:5Reverse split
    Nov 22, 20195 shares → 1
Balance Sheet Details
Assets$420K
Liabilities$1.53M
Accounts Receivable$37K
Accounts Payable$0
Inventory$0
PP&E (Net)$110K
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2026FY 2025FY 2024FY 2023FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2026-06-302025-06-302024-06-302023-06-302021-06-302020-06-302019-06-302018-06-302017-06-302015-12-312014-12-312013-12-312012-12-31
Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0
YoY Growth-------------
Cost of Revenue$59K$7K$20K$23K$44K$45K$58K$87K$77K$52K$2K$0$0
Gross Profit-$59K-$7K-$20K-$23K-$44K-$45K-$58K-$87K-$77K-$52K-$2K$0$0
Gross Margin-------------
Research and Development$632K$709K$954K$955K$423K$255K$138K$1.08M$784K$69K$9K$0$0
Selling, General, and Administrative$789K$671K$1.01M$1.02M$457K$662K$600K$2.15M$5.73M$51K$78K$22K$69K
Other$0$0$0$0$128K$67K$0$8K$0$0$0$0$0
Total Operating Expenses$1.42M$1.38M$1.96M$1.97M$880K$918K$737K$3.23M$6.51M$51K$78K$22K$69K
Operating Income (EBIT)-$1.48M-$1.89M-$1.96M-$1.97M-$752K-$851K-$737K-$3.15M-$6.51M-$51K-$78K-$32K-$86K
Operating Margin-------------
Interest Expense$129K$3K$3K$4K$0$19K$14K$0$0$0$0$0$0
Interest Income$0$0$0$0$0$0$0$0$0$2K$2K$6K$3K
Other Income (Expense)-$94K-$11K$62K-$4K$128K$48K-$14K-$16K-$429K-$1.18M-$202K$6K$3K
Income Before Tax (EBT)-$1.57M-$1.9M-$1.9M-$1.97M-$749K-$869K-$752K-$3.29M-$6.94M-$49K-$76K-$26K-$83K
Income Tax Expense-$10K$0$0$0$0$0$0$69K$0-$52K-$14K$0$0
Net Income-$1.56M-$1.9M-$1.9M-$1.97M-$749K-$869K-$752K-$3.29M-$6.94M-$49K-$76K-$26K-$83K
Net Income Margin-------------
Supplementary Data
EPS-0.02-0.02-0.04-0.05-0.02-0.04-0.02-0.08-0.21-0.02-0.03-0.01-0.03
Diluted EPS-0.02-0.02-0.04-0.05-0.02-0.04-0.02-0.08-0.21-0.02-0.03-0.01-0.03
Weighted Average OS100.32M87.74M71.38M60.15M46.89M41.35M45.38M59.77M47.70M4.40M4.21M4.25M3.94M
EBITDA-$1.42M-$1.88M-$1.88M-$1.95M-$833K-$805K-$679K-$3.07M-$5.16M-$1.17M-$182K-$12K-$52K
EBITDA Margin-------------
Balance Sheet
PeriodFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2026-06-302025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302015-12-312014-12-312013-12-312012-12-312011-12-31
Assets
Current Assets
Cash and Cash Equivalents$237K$406K$557K$1.87M$1.89M$2.55M$645K$14K$47K$840K$223K$322K$355K$380K$393K
Short-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$237K$553K$557K$1.87M$1.89M$2.55M$645K$14K$47K$840K$223K$322K$355K$380K$393K
Accounts Receivable$37K$19K$22K$45K$27K$68K$0$0$0$0$0$0$6K$5K$6K
Inventory$0$0$0$0$0$0$0$0$0$0-$10K-$18K$0$0$0
Other Current Assets$0-$166K$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Current Assets$310K$459K$643K$1.99M$1.95M$2.63M$726K$58K$117K$1.54M$421K$326K$360K$384K$398K
Long-Term Assets
Property, Plant & Equipment Net$110K$10K$21K$46K$21K$43K$80K$126K$184K$327K$87K$3K$0$0$0
Goodwill$0$0$0-$20K$11K-$43K$11K$0$0$0$0$0$0$0$0
Intangible Assets$0$0$11K$31K$17$55K$92$0$0$0$455K$207K$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$0$0$0$0$0$0$0$0$0$313K$0$0$0$0$0
Total Long-Term Assets$110K$10K$33K$58K$33K$55K$92K$126K$184K$640K$542K$210K$0$0$0
Other Assets$0$0$0$0$0$0$0$0$0$0-$542K-$210K$0$0$0
Total Assets$420K$469K$676K$2.05M$1.98M$2.69M$818K$184K$301K$2.18M$421K$326K$360K$384K$398K
Liabilities
Current Liabilities
Accounts Payable$0$0$186K$0$133$72K$229K$561K$443K$561K$0$0$0$0$0
Short-Term Debt$984K$0$0$0$0$0$0$196K$0$0$242K$0$0$0$0
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$0$0$0$0-$719K$0$0-$1.09M$0$0$0$0
Other Current Liabilities$518K$204K$0$196K$0$0$18K$158K$78K$47K$194K-$50K$12K$10K$11K
Total Current Liabilities$1.5M$204K$263K$196K$133K$80K$247K$915K$520K$608K$24K$11K$12K$10K$11K
Long-Term Liabilities
Long-Term Debt$0$0$0$23K$28K$28K$28K$0$0$0$0$0$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$0$0$0$0$0$0$0$12K$0$0$0$0$0
Total Long-Term Liabilities$27K$0$0$23K$28K$28K$28K$0$0$12K$0$57K$0$0$0
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0-$57K$0$0$0
Total Liabilities$1.53M$204K$263K$219K$161K$108K$275K$915K$520K$620K$24K$11K$12K$10K$11K
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Common Stock$17.24M$17.2M$15.64M$15.18M$13.37M$12.76M$10.03M$8.22M$8.01M$7.28M$1.02M$333K$0$0$0
Retained Earnings-$23.01M-$21.39M-$19.48M-$17.58M-$15.61M-$14.13M-$13.38M-$12.51M-$11.76M-$8.47M-$221K-$172K-$139K-$113K-$100K
Comprehensive Income & Other$0$0$0$0$0$0$0$0$3.53M$0$0$0$70K$70K$70K
Other Stockholders' Equity$4.66M$4.54M$4.25M$4.23M$4.06M$3.95M$3.9M$3.56M$3.53M$2.75M-$407K$153K$487K$487K$487K
Total Equity-$1.11M$360K$413K$1.83M$1.82M$2.58M$543K-$731K-$220K$1.56M$397K$314K$349K$375K$388K
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$420K$564K$676K$2.05M$1.98M$2.69M$818K$184K$301K$2.18M$421K$326K$360K$384K$398K
Supplementary Data
Total Debt$1.01M$0$0$23K$28K$28K$28K$196K$0$0$242K$142K$0$0$0
Net Debt$774K-$406K-$557K-$1.85M-$1.86M-$2.52M-$617K$182K-$47K-$840K$19K-$180K-$355K-$380K-$393K
Cash Flow Statement
PeriodFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2026-06-302025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302015-12-312014-12-312013-12-312012-12-31
Operating Activities
Net Income-$1.56M-$1.9M-$1.9M-$1.97M-$1.48M-$749K-$869K-$752K-$3.29M-$6.94M-$49K-$76K-$26K-$83K
Depreciation & Amortization$59K$10K$28K$23K$40K$44K$45K$58K$87K$77K$52K$52K$0$0
Deferred Income Tax$0$0$0$0-$145K-$3K$0$0$72K$427K$0$0$0$0
Stock-Based Compensation$0$188K$45K$112K$106K$99K$252K$30K$41K$916K$275$167$0$43K
Changes in Working Capital:
  Accounts Receivable-$18K$3K$23K-$18K$41K-$33K-$9K$3K$204K-$196K-$25K$0$0$0
  Inventory$0$0$0$0$0$0$0$0$0$0$0$0$0$0
  Accounts Payable$0$0$0$0$0$0$0$0$0$0$0$0$0$0
  Other Working Capital$285K$25K$88K$17K$34K-$3K-$136K$221K$653K-$748K$322K-$16$0$0
Total Working Capital Change$267K$29K$111K-$1K$75K-$36K-$144K$224K$857K-$944K-$6K$1K$1K-$7K
Other Non-Cash Items$162K$480K-$6K$85K$145K-$128K-$67K$210K-$15K$1.36M$424K-$52K$0$43K
Net Cash from Operating-$1.08M-$1.2M-$1.72M-$1.84M-$1.26M-$773K-$784K-$229K-$2.24M-$5.53M-$55K-$75K-$25K-$47K
Investing Activities
Capital Expenditures-$13K-$2K-$4K-$48K-$18K-$7K-$6K$0-$16K-$334K-$288K-$3$0$0
Acquisitions$0$0$0$0$0$0$0$0$0$98K$0$0$0$0
Purchases of Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Sales of Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Investing Activities$0$0$0$0$0$0-$6$0$804-$18K-$175K-$205$0$0
Net Cash from Investing-$13K-$2K-$4K-$48K-$18K-$7K-$6K$0-$15K-$97K-$175K-$208$0$0
Financing Activities
Debt Repaid--$16K$5K-$11K-$273K--$47K----
Common Stock Issuance$0$1.2M$455K$1.98M$137K$1.46M$1.21M$0$1.49M$6.97M$0$0$0$420K
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities-$153K-$154K-$28K-$103K$614K$1.22M-$67K$196K-$19K-$477K$0$42K$0-$43K
Net Cash from Financing$783K$1.2M$411K$1.88M$614$2.68M$1.42M$196K$1.47M$6.44M$131K$42K$0$377K
Forex Effect-$23K$2K$0$0$0$0$0$0$0$0$0$0$0$0
Net Change in Cash-$328K-$1K-$1.31M-$14K-$660K$1.9M$631K-$33K-$793K$813K-$99K-$33K-$25K$330K
Supplementary Data
Operating Cash Flow-$1.08M-$1.63M-$1.72M-$1.84M-$1.26M-$773K-$784K-$229K-$2.24M-$5.53M-$55K-$75K-$25K-$47K
Capital Expenditure-$13K-$2K-$4K-$48K-$18K-$7K-$6K$0-$16K-$334K-$288K-$3$0$0
Free Cash Flow-$1.09M-$1.63M-$1.73M-$1.89M-$1.27M-$780K-$790K-$229K-$2.26M-$5.86M-$343K-$75K-$25K-$47K
Cash at Beginning$557K$407K$1.87M$1.89M$2.55M$645K$14K$47K$840K$27K$322K$355K$380K$49K
Cash at End$229K$406K$557K$1.87M$1.89M$2.55M$645K$14K$47K$840K$223K$322K$355K$380K